Avenir Wellness Solutions, Inc.

AVRW

US23127P1049

Software

Market Closed - OTC Markets Other stock markets 10:58:40 29/05/2024 pm IST			5-day change	1st Jan Change
0.0389 ^USD	-0.26%		0.00%	-47.72%

17/05	Avenir Wellness Solutions, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
12/01	Avenir Wellness Solutions, Inc. and Nancy Duitch Enters into Certain Senior Secured Promissory Note and Security Agreement	CI

CURE Pharmaceutical Holding Corp. Appoints John K. Bell to its Board of Directors

March 13, 2020

CURE Pharmaceutical names Canopy Rivers Chairman John K. Bell, FCA, FCPA, ICD.D to its board of directors. Bell brings more than 40 years of experience to the company, most recently serving as chairman of the Canopy Rivers board of directors and former chairman of Canopy Growth's board of directors.

Latest news about Avenir Wellness Solutions, Inc.

Avenir Wellness Solutions, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	17/05	CI
Avenir Wellness Solutions, Inc. and Nancy Duitch Enters into Certain Senior Secured Promissory Note and Security Agreement	12/01	CI
Avenir Wellness Solutions, Inc. announced that it expects to receive $0.25 million in funding	04/01	CI
Avenir Wellness Solutions, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	15/11	CI
Avenir Wellness Solutions, Inc. Provides Sales Guidance for the Second Half of 2023	15/23/15	CI
Avenir Wellness Solutions, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	15/23/15	CI
Avenir Wellness Solutions, Inc. will Change its Ticker to AVRW from CURR	09/23/09	CI
Avenir Wellness Solutions, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	29/23/29	CI
Avenir Wellness Solutions, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	29/23/29	CI
Avenir Wellness Solutions to Launch Wall Street-Focused Informational Series with Producer New to the Street	19/23/19	CI
CURE Pharmaceutical Holding Corp. has Changed its Name to Avenir Wellness Solutions, Inc	17/23/17	CI
CURE Pharmaceutical Holding Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22/22/22	CI
CURE Pharmaceutical Holding Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	02/22/02	CI
CURE Pharmaceutical Holding Corp. Announces Board and Committee Appointments	16/22/16	CI
CURE Pharmaceutical Holding Corp. Appoints Gerald Bagg to Its Board of Directors	02/22/02	CI
CURE Pharmaceutical Holding Corp. Reports Earnings Results for the First Quarter Ended March 31, 2022	17/22/17	CI
CURE Pharmaceutical Holding Corp. Reports Earnings Results for the Full Year Ended December 31, 2021	01/22/01	CI
CURE Pharmaceutical Holding Corp. Auditor Raises 'Going Concern' Doubt	01/22/01	CI
CURE Pharmaceutical and Milagro Pharmaceuticals Collaborate for Registration and Approval to Sell Sildenafil Oral Thin Film in Mexico	03/22/03	CI
CURE Pharmaceutical Holding Corp. Announces Resignation of Directors	04/21/04	CI
CURE Pharmaceutical Holding Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	16/21/16	CI
CURE Pharmaceutical Holding Corp. Reports Earnings Results for the Second Quarter Ended June 30, 2021	17/21/17	CI
CURE Pharmaceutical Holding Corp. Announces Revenue Results for the First Quarter Ended March 31, 2021	17/21/17	CI
Cure Pharmaceutical Holding Corp. Reports Earnings Results for the First Quarter Ended March 31, 2021	17/21/17	CI
CURE Pharmaceutical Holding Corp. Announces Successful Results from Initial Clinical Trials for Erectile Dysfunction Product CUREfilm Blue	21/21/21	CI

Chart Avenir Wellness Solutions, Inc.

Duration

Period

More charts

Company Profile

Avenir Wellness Solutions, Inc. is a platform technology company. The Company develops proprietary wellness, nutraceutical, and topical delivery systems. The Company is focused on the development of nutraceutical formulation and delivery technologies in novel dosage forms to improve wellness. Its wholly owned subsidiary, The Sera Labs, Inc. (Sera Labs), is engaged the development, production and sale of the Companyâs wellness and beauty products. Sera Labs creates products that use science-backed, proprietary oral and topical formulations. The Company sells over 25 products under the brand names Seratopical, Seratopical Revolution SeraLabs, and Nutri-Stri. Sera Labs products are sold direct-to-consumer via online Website orders, including opt-in subscribe and save option, and also online and in-store at national drug, mass retailers, grocery chains and convenience stores and on Amazon.com.

Sector

Software

Calendar

13/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Software

	1st Jan change	Capi.
AVENIR WELLNESS SOLUTIONS, INC.	-47.72%	2.85M
MICROSOFT CORPORATION	+14.08%	3,190B
SYNOPSYS INC.	+12.60%	88.9B
CADENCE DESIGN SYSTEMS, INC.	+7.10%	79.38B
DASSAULT SYSTÈMES SE	-14.00%	54.13B
PALANTIR TECHNOLOGIES INC.	+21.96%	46.63B
THE TRADE DESK, INC.	+32.64%	46.69B
ATLASSIAN CORPORATION	-30.31%	43.15B
SEA LIMITED	+68.07%	39.1B
TAKE-TWO INTERACTIVE SOFTWARE, INC.	-0.83%	27.37B

Other Software

Avenir Wellness Solutions, Inc.

Equities

AVRW

US23127P1049

Software

CURE Pharmaceutical Holding Corp. Appoints John K. Bell to its Board of Directors

Latest news about Avenir Wellness Solutions, Inc.

Chart Avenir Wellness Solutions, Inc.

Company Profile

Income Statement Evolution

Sector Other Software